GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (STU:9UA) » Definitions » Other Gross PPE

NervGen Pharma (STU:9UA) Other Gross PPE : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is NervGen Pharma Other Gross PPE?

NervGen Pharma's Other Gross PPE for the quarter that ended in Dec. 2024 was €0.00 Mil.

NervGen Pharma's quarterly Other Gross PPE declined from Jun. 2024 (€0.00 Mil) to Sep. 2024 (€0.00 Mil) and declined from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€0.00 Mil).

NervGen Pharma's annual Other Gross PPE declined from Dec. 2022 (€0.21 Mil) to Dec. 2023 (€0.14 Mil) and declined from Dec. 2023 (€0.14 Mil) to Dec. 2024 (€0.00 Mil).


NervGen Pharma Other Gross PPE Historical Data

The historical data trend for NervGen Pharma's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma Other Gross PPE Chart

NervGen Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial - - 0.21 0.14 -

NervGen Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.12 - - -

NervGen Pharma Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


NervGen Pharma Business Description

Traded in Other Exchanges
Address
112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.

NervGen Pharma Headlines

No Headlines